STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.

Auteurs

van Loosbroek SY, Milder MTW, de Ruysscher D, Vaes RDW, den Toom W, Willemssen F, Eskens F, Homs MYV, Groot Koerkamp B, van Driel LMJW, Seppenwoolde Y, van Werkhoven E, Intven M, Haj Mohammad N, de Bruijne J, Versteijne E, Bruynzeel AM, Brandts F, Erdmann JI, Westdorp H, Braam PM, Tjwa ETTL, Bouchart C, Demols A, Gulyban A, Buijsen J, de Vos-Geelen J, Dewulf M, Joye I, Vandamme T, Vonghia L, de Groot DJ, Dieters M, Ubbels FJF, Hoogwater FJH, Heijmen B, Méndez Romero A

  • Date de publication

    July 2025
  • Type

    Article
  • Review

    BMJ Open
  • Researcher's name

    BOUCHART CHRISTELLE
  • Hôpital

    Institut Jules Bordet
  • Service

    Radiothérapie, Radiotherapy
  • PMID

    40669914
  • DOI

    10.1136/bmjopen-2024-097545